Mabpharm Limited (2181.HK)

HKD 0.3

(-4.76%)

Total Assets Summary of Mabpharm Limited

Mabpharm Limited's latest annual total assets in 2023 was 1.03 Billion CNY , up 12.8% from previous year.
Mabpharm Limited's latest quarterly total assets in 2024 Q2 was 946.39 Million CNY , down 0.0% from previous quarter.
Mabpharm Limited reported annual total assets of 917.52 Million CNY in 2022, up 1.96% from previous year.
Mabpharm Limited reported annual total assets of 899.9 Million CNY in 2021, down -22.62% from previous year.
Mabpharm Limited reported quarterly total assets of 946.39 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Mabpharm Limited reported quarterly total assets of 1.03 Billion CNY for 2023 Q3, up 14.62% from previous quarter.

Annual Total Assets Chart of Mabpharm Limited (2023 - 2017)

Historical Annual Total Assets of Mabpharm Limited (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	1.03 Billion CNY	12.8%
2022	917.52 Million CNY	1.96%
2021	899.9 Million CNY	-22.62%
2020	1.16 Billion CNY	-16.72%
2019	1.39 Billion CNY	195.1%
2018	473.22 Million CNY	63.66%
2017	289.14 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	946.39 Million CNY	-8.56%
2024 Q2	946.39 Million CNY	0.0%
2023 Q3	1.03 Billion CNY	14.62%
2023 Q2	902.94 Million CNY	0.0%
2023 Q1	902.94 Million CNY	-1.59%
2023 Q4	1.03 Billion CNY	0.0%
2023 FY	1.03 Billion CNY	12.8%
2022 Q1	938 Million CNY	4.23%
2022 FY	917.52 Million CNY	1.96%
2022 Q3	917.52 Million CNY	-2.18%
2022 Q2	938 Million CNY	0.0%
2022 Q4	917.52 Million CNY	0.0%
2021 FY	899.9 Million CNY	-22.62%
2021 Q4	899.9 Million CNY	0.0%
2021 Q3	899.9 Million CNY	-8.04%
2021 Q1	978.62 Million CNY	-15.86%
2021 Q2	978.62 Million CNY	0.0%
2020 Q4	1.16 Billion CNY	0.0%
2020 FY	1.16 Billion CNY	-16.72%
2020 Q2	1.31 Billion CNY	0.0%
2020 Q1	1.31 Billion CNY	-5.67%
2020 Q3	1.16 Billion CNY	-11.71%
2019 Q1	1.4 Billion CNY	197.39%
2019 FY	1.39 Billion CNY	195.1%
2019 Q4	1.39 Billion CNY	0.0%
2019 Q3	1.39 Billion CNY	-0.77%
2019 Q2	1.4 Billion CNY	0.0%
2018 FY	473.22 Million CNY	63.66%
2018 Q1	- CNY	0.0%
2018 Q4	473.22 Million CNY	0.0%
2018 Q3	473.22 Million CNY	0.0%
2017 FY	289.14 Million CNY	0.0%

Peer Total Assets Comparison of Mabpharm Limited

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-152.437%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	90.798%